2Marty F M,Lowry C M,Lempitski S J,et al.Reactivity of(1,3)-β-D-glucan assay with commonly used intravenous antimicrobials.Antimicrob Agents Chemother,2006,50:3450-3453.
3Hope W W,Walsh T J,Denning D W.Laboratory diagnosis of invasive aspergillosis.Lancet Infect Dis,2005,5:609-622.
4L.Ostrosky-Zeichner.Combination antifungal therapy:a critical review of the evidence.Clin Microbiol Infect,2008,14(Suppl 4):S65-70.
5Schuster F,Moelter C.Schmid I,et al.Successful antifungal combination therapy with voriconazole and caspofungin.Pediatr Blood Cancer,2005,44:682-685.
6Kaffarnik M,Utzolino S,Blaich A,et al.Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient:case report and review of the literature.Mycoses,2008,51:74-78.
2Stevens DA,Kan VL,Judson MA,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America.Clin Infect Dis,2000,30:696-709.
3Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14.
4Denning DW,Kibbler CC,Barnes RA,et al.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.Lancet Infect Dis,2003,3:230-240.
5Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis.Clin Infect Dis,2004,38:161-189.
6Slavin MA,Szer J,Grigg AP,et al.Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.Intern Med J,2004,34:192-200.
7Saag MS,Graybill RJ,Larsen RA,et al.Practice guidelines for the management of cryptococcal disease.Infectious Diseases Society of America.Clin Infect Dis,2000,30:710-718.
3GOLD Executive Committee. Global strategy for the diagnosis, manage- ment, and prevention of chronid obstructive pulmonary disease (Revised 2011 ). www. goldcopd, com.
4Bulpa P,Dive A. Invasive pulmonary aspergillosis in patients with chro- nic obstructive pulmonary- disease. Eur Respir J ,2007,30:782-800.
5Limper AH, Knox KS, Sarosi GA, et al. An official American thoracic society statement:treatment of fungal infections in adult pulmonary and critical care patients. Am J Respi Crit Care Med,2011,183:96-128.
